Inventia | Resources

Integration of RASTRUM™ and AlphaLISA® for drug discovery in 3D cell cultures

Written by Inventia | Jan 18 2019

Highlights

In this application note, the RASTRUM™ 3D Cell Culture Platform, developed by Inventia Life Science, has been implemented with the Alpha technology to establish a high-throughput 3D cell culture workflow using non-invasive and invasive breast cancer cell lines, which were assayed for cytokine release and intracellular kinases.